Mednax Extraordinary Items vs Net Income From Continuing Ops Analysis

MD Stock

USD 9.04 0.14 1.57%

Mednax financial indicator trend analysis is infinitely more than just investigating Mednax Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mednax Inc is a good investment. Please check the relationship between Mednax Extraordinary Items and its Net Income From Continuing Ops accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

Extraordinary Items vs Net Income From Continuing Ops

Extraordinary Items vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mednax Inc Extraordinary Items account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Mednax's Extraordinary Items and Net Income From Continuing Ops is 0.47. Overlapping area represents the amount of variation of Extraordinary Items that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Mednax Inc, assuming nothing else is changed. The correlation between historical values of Mednax's Extraordinary Items and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Extraordinary Items of Mednax Inc are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Extraordinary Items i.e., Mednax's Extraordinary Items and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.47

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Extraordinary Items

Net Income From Continuing Ops

Most indicators from Mednax's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mednax Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

At present, Mednax's Discontinued Operations is projected to decrease significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 6.9 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.11.

	2021	2022	2023	2024 (projected)
Gross Profit	513.2M	467.0M	421.6M	542.2M
Total Revenue	1.9B	2.0B	2.0B	1.5B

Gross Profit Total Revenue

Mednax fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock Total Equity	Common Stock	Other Liab	Other Assets
Total Assets		0.79	0.54	0.64	0.86	-0.16	0.86	0.74	0.8	0.0	0.98	-0.09	-0.01	0.95	0.59	0.85	0.22	0.82	0.85	0.1	0.42	-0.26	0.67	0.71	0.63	0.22
Short Long Term Debt Total	0.79		0.08	0.56	0.38	-0.32	0.92	0.25	0.74	0.37	0.7	0.19	0.37	0.78	0.1	0.99	-0.06	0.65	0.99	0.26	0.67	0.0	0.55	0.57	0.73	0.48
Other Current Liab	0.54	0.08		0.22	0.77	0.1	0.3	0.7	0.04	-0.52	0.63	-0.22	-0.49	0.48	0.52	0.14	-0.04	0.4	0.15	0.22	-0.25	-0.15	0.36	0.35	0.34	-0.35
Total Current Liabilities	0.64	0.56	0.22		0.45	0.39	0.53	0.28	0.45	0.16	0.58	-0.46	0.16	0.71	0.62	0.6	0.4	0.8	0.64	0.25	0.49	0.33	0.59	0.6	0.56	0.31
Total Stockholder Equity	0.86	0.38	0.77	0.45		0.03	0.55	0.95	0.58	-0.34	0.91	-0.3	-0.35	0.78	0.75	0.45	0.35	0.63	0.46	-0.08	0.03	-0.45	0.49	0.53	0.31	-0.05
Property Plant And Equipment Net	-0.16	-0.32	0.1	0.39	0.03		-0.29	0.05	-0.4	-0.14	-0.13	-0.92	-0.14	-0.16	0.22	-0.31	0.32	-0.1	-0.3	-0.07	-0.17	0.3	-0.34	-0.34	-0.24	-0.16
Net Debt	0.86	0.92	0.3	0.53	0.55	-0.29		0.45	0.68	-0.02	0.84	0.09	-0.02	0.89	0.15	0.92	-0.18	0.63	0.92	0.24	0.35	-0.07	0.53	0.55	0.69	0.52
Retained Earnings	0.74	0.25	0.7	0.28	0.95	0.05	0.45		0.52	-0.43	0.82	-0.37	-0.44	0.65	0.65	0.31	0.33	0.43	0.31	-0.3	-0.12	-0.63	0.3	0.34	0.06	-0.09
Accounts Payable	0.8	0.74	0.04	0.45	0.58	-0.4	0.68	0.52		0.3	0.72	0.15	0.27	0.75	0.44	0.78	0.36	0.64	0.78	-0.12	0.59	-0.44	0.59	0.64	0.38	0.36
Cash	0.0	0.37	-0.52	0.16	-0.34	-0.14	-0.02	-0.43	0.3		-0.2	0.27	1.0	-0.14	-0.11	0.35	0.29	0.17	0.35	0.08	0.9	0.15	0.15	0.16	0.23	0.0
Non Current Assets Total	0.98	0.7	0.63	0.58	0.91	-0.13	0.84	0.82	0.72	-0.2		-0.14	-0.21	0.95	0.59	0.76	0.16	0.75	0.76	0.07	0.23	-0.3	0.61	0.65	0.56	0.2
Non Currrent Assets Other	-0.09	0.19	-0.22	-0.46	-0.3	-0.92	0.09	-0.37	0.15	0.27	-0.14		0.28	-0.08	-0.4	0.16	-0.4	-0.04	0.15	0.31	0.2	-0.06	0.22	0.2	0.23	0.15
Cash And Short Term Investments	-0.01	0.37	-0.49	0.16	-0.35	-0.14	-0.02	-0.44	0.27	1.0	-0.21	0.28		-0.14	-0.12	0.35	0.27	0.18	0.34	0.14	0.9	0.17	0.16	0.17	0.25	0.0
Net Receivables	0.95	0.78	0.48	0.71	0.78	-0.16	0.89	0.65	0.75	-0.14	0.95	-0.08	-0.14		0.55	0.82	0.1	0.83	0.84	0.18	0.31	-0.1	0.71	0.74	0.67	0.4
Common Stock Shares Outstanding	0.59	0.1	0.52	0.62	0.75	0.22	0.15	0.65	0.44	-0.11	0.59	-0.4	-0.12	0.55		0.2	0.69	0.74	0.25	-0.12	0.18	-0.16	0.56	0.58	0.23	-0.22
Non Current Liabilities Total	0.85	0.99	0.14	0.6	0.45	-0.31	0.92	0.31	0.78	0.35	0.76	0.16	0.35	0.82	0.2		0.0	0.72	1.0	0.23	0.68	-0.02	0.62	0.64	0.75	0.43
Other Current Assets	0.22	-0.06	-0.04	0.4	0.35	0.32	-0.18	0.33	0.36	0.29	0.16	-0.4	0.27	0.1	0.69	0.0		0.36	0.03	-0.36	0.37	-0.34	0.14	0.18	-0.23	-0.1
Other Stockholder Equity	0.82	0.65	0.4	0.8	0.63	-0.1	0.63	0.43	0.64	0.17	0.75	-0.04	0.18	0.83	0.74	0.72	0.36		0.76	0.23	0.55	0.09	0.86	0.86	0.74	0.11
Total Liab	0.85	0.99	0.15	0.64	0.46	-0.3	0.92	0.31	0.78	0.35	0.76	0.15	0.34	0.84	0.25	1.0	0.03	0.76		0.25	0.68	0.0	0.66	0.68	0.77	0.44
Property Plant And Equipment Gross	0.1	0.26	0.22	0.25	-0.08	-0.07	0.24	-0.3	-0.12	0.08	0.07	0.31	0.14	0.18	-0.12	0.23	-0.36	0.23	0.25		0.2	0.57	0.28	0.22	0.61	0.29
Total Current Assets	0.42	0.67	-0.25	0.49	0.03	-0.17	0.35	-0.12	0.59	0.9	0.23	0.2	0.9	0.31	0.18	0.68	0.37	0.55	0.68	0.2		0.1	0.47	0.49	0.51	0.16
Short Term Debt	-0.26	0.0	-0.15	0.33	-0.45	0.3	-0.07	-0.63	-0.44	0.15	-0.3	-0.06	0.17	-0.1	-0.16	-0.02	-0.34	0.09	0.0	0.57	0.1		0.09	0.05	0.43	0.09
Common Stock Total Equity	0.67	0.55	0.36	0.59	0.49	-0.34	0.53	0.3	0.59	0.15	0.61	0.22	0.16	0.71	0.56	0.62	0.14	0.86	0.66	0.28	0.47	0.09		0.99	0.7	0.08
Common Stock	0.71	0.57	0.35	0.6	0.53	-0.34	0.55	0.34	0.64	0.16	0.65	0.2	0.17	0.74	0.58	0.64	0.18	0.86	0.68	0.22	0.49	0.05	0.99		0.69	0.08
Other Liab	0.63	0.73	0.34	0.56	0.31	-0.24	0.69	0.06	0.38	0.23	0.56	0.23	0.25	0.67	0.23	0.75	-0.23	0.74	0.77	0.61	0.51	0.43	0.7	0.69		0.15
Other Assets	0.22	0.48	-0.35	0.31	-0.05	-0.16	0.52	-0.09	0.36	0.0	0.2	0.15	0.0	0.4	-0.22	0.43	-0.1	0.11	0.44	0.29	0.16	0.09	0.08	0.08	0.15

Click cells to compare fundamentals

Mednax Account Relationship Matchups

Mednax fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.1B	3.3B	2.7B	2.3B	2.2B	2.2B
Short Long Term Debt Total	1.8B	1.8B	1.1B	753.6M	701.6M	521.4M
Other Current Liab	(23.4M)	(21.2M)	(22.2M)	200.0M	350.8M	368.3M
Total Current Liabilities	511.9M	423.2M	394.1M	374.2M	388.9M	284.3M
Total Stockholder Equity	1.5B	747.7M	896.7M	891.6M	849.1M	1.2B
Property Plant And Equipment Net	82.8M	56.0M	65.5M	66.9M	145.9M	285.9M
Net Debt	1.7B	680.9M	678.4M	743.7M	628.4M	431.5M
Retained Earnings	510.2M	(286.4M)	(155.4M)	(89.1M)	(149.5M)	(142.0M)
Accounts Payable	511.9M	423.2M	394.1M	31.9M	34.6M	32.9M
Cash	112.8M	1.1B	387.4M	9.8M	73.3M	89.9M
Non Current Assets Total	3.5B	1.8B	2.0B	2.0B	1.7B	1.9B
Non Currrent Assets Other	(162.4M)	107.4M	(88.3M)	(105.9M)	82.2M	86.3M
Cash And Short Term Investments	112.8M	1.2B	387.4M	9.8M	177.7M	106.1M
Net Receivables	498.9M	241.9M	301.8M	296.8M	279.9M	228.1M
Common Stock Shares Outstanding	83.5M	83.4M	85.8M	84.1M	82.2M	77.1M
Liabilities And Stockholders Equity	4.1B	3.3B	2.7B	2.3B	2.2B	2.2B
Non Current Liabilities Total	2.1B	2.2B	1.4B	1.1B	981.8M	731.0M
Other Current Assets	45.4M	78.7M	51.7M	28.1M	12.3M	11.7M
Other Stockholder Equity	987.9M	1.0B	1.0B	983.6M	999.9M	695.6M
Total Liab	2.6B	2.6B	1.8B	1.5B	1.4B	982.2M
Property Plant And Equipment Gross	177.3M	132.2M	70.2M	73.3M	288.6M	303.1M
Total Current Assets	657.0M	1.5B	740.8M	334.8M	483.5M	382.4M
Accumulated Other Comprehensive Income	78K	3.5M	1.3M	(3.7M)	(2.2M)	(2.3M)
Short Term Debt	23.4M	21.2M	22.2M	36.5M	36.0M	37.8M
Common Stock Total Equity	842K	856K	864K	829K	953.4K	643.9K
Common Stock	842K	856K	864K	829K	840K	655.1K
Other Liab	330.2M	372.4M	365.9M	348.7M	401.0M	421.0M
Other Assets	1.8B	217.8M	219.4M	229.1M	263.5M	212.4M
Intangible Assets	274.4M	26.6M	21.6M	18.5M	21.2M	20.2M
Property Plant Equipment	129.1M	76.2M	70.2M	73.3M	84.3M	64.4M
Long Term Debt	1.7B	1.7B	1.0B	636.4M	611.6M	643.8M
Good Will	3.1B	1.7B	1.8B	1.8B	1.4B	2.2B
Short Term Investments	74.5M	104.9M	99.7M	93.2M	104.5M	109.7M
Net Tangible Assets	(9.4M)	(757.1M)	896.5M	891.6M	1.0B	1.1B
Long Term Debt Total	1.7B	1.7B	1.0B	636.4M	731.8M	1.1B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Mednax Inc is a strong investment it is important to analyze Mednax's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mednax's future performance. For an informed investment choice regarding Mednax Stock, refer to the following important reports:

How To Invest In Mednax

Details

Is Mednax Stock a good investment?

Details

What is Mednax's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

Note that the Mednax Inc information on this page should be used as a complementary analysis to other Mednax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Mednax Stock analysis

When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.

	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	FinTech Suite Use AI to screen and filter profitable investment opportunities

Is Mednax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.31)

Revenue Per Share

24.265

Quarterly Revenue Growth

(0.03)

Return On Assets

0.0432

Return On Equity

(0.07)

The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mednax Extraordinary Items vs Net Income From Continuing Ops Analysis

Extraordinary Items vs Net Income From Continuing Ops

Extraordinary Items vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Extraordinary Items

Net Income From Continuing Ops

Mednax fundamental ratios Correlations

Mednax Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Mednax fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Mednax Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Common Stock	+ 0.99	Common Stock Total Equity
Non Current Assets Total	+ 0.98	Total Assets

Non Currrent Assets Other	- 0.92	Property Plant And Equipment Net
Short Term Debt	- 0.63	Retained Earnings
Cash	- 0.52	Other Current Liab
Cash And Short Term Investments	- 0.49	Other Current Liab
Non Currrent Assets Other	- 0.46	Total Current Liabilities
Short Term Debt	- 0.45	Total Stockholder Equity